European patent application EP4629936A2, titled 'DEVICE FOR TREATING VALVULAR INSUFFICIENCY AND METHOD OF DELIVERING SAME', was published by the EPO on March 11, 2026. The application, filed by Coramaze Technologies Ltd., outlines a novel device and method for treating valvular insufficiency, with specific IPC classifications including A61F 2/24, A61B 17/12, A61M 25/10, and A61B 17/22. The patent is designated for use in multiple European states.

This publication represents a new patent filing and does not impose immediate compliance obligations on regulated entities. However, it is relevant for medical device manufacturers and healthcare providers involved in the development or use of treatments for valvular insufficiency. Companies operating in this space should be aware of this patent application as it may impact future product development, licensing, or market entry strategies within the designated European countries.